chr16-84191243-T-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001145400.2(ADAD2):āc.13T>Gā(p.Ser5Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,607,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001145400.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAD2 | NM_001145400.2 | c.13T>G | p.Ser5Ala | missense_variant | 1/10 | ENST00000315906.10 | NP_001138872.1 | |
ADAD2 | NM_139174.4 | c.13T>G | p.Ser5Ala | missense_variant | 1/11 | NP_631913.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAD2 | ENST00000315906.10 | c.13T>G | p.Ser5Ala | missense_variant | 1/10 | 1 | NM_001145400.2 | ENSP00000325153.6 | ||
ADAD2 | ENST00000268624.7 | c.13T>G | p.Ser5Ala | missense_variant | 1/11 | 2 | ENSP00000268624.3 | |||
ADAD2 | ENST00000567413.1 | n.53T>G | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.00000424 AC: 1AN: 235632Hom.: 0 AF XY: 0.00000771 AC XY: 1AN XY: 129658
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1455570Hom.: 0 Cov.: 88 AF XY: 0.0000152 AC XY: 11AN XY: 723370
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152204Hom.: 0 Cov.: 35 AF XY: 0.0000134 AC XY: 1AN XY: 74356
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at